Scientific Area

Phases of the Project

Click here

Project Publications

Click Here

Related Projects and Research

Click Here

Related Policy and Legislation

Click Here

Mid-Project Report

Click Here

NUI Galway

Project input by NUIG will include expertise in stem cell research, diabetic ulceration and bone fractures, and scale-up of cell isolation for GMP production. Prof. O’Brien is a Consultant Physician in Endocrinology and is a registered specialist in the EU and a Board Certified specialist in the USA. Professor Timothy O’Brien – timothy.obrien@nuigalway.ie Director of REMEDI (the…
The Queen’s University of Belfast

Project input will include expertise in retinopathy. Professor Alan Stitt – a.stitt@qub.ac.uk Leader of the Centre for Vision and Vascular Science at QUB Website: www.qub.ac.uk/
Universidade do Porto

Project input will include analysis and evaluation of impacts on the nervous system. Professor Isaura Tavares – isatav@med.up.pt Specialist in diabetic neuropathy Website: http://www.up.pt
Charité – Universitätsmedizin Berlin

Project input will include evaluating impact of SSC transplantation on diabetic cardiomyopathy. Professor Carsten Tschoepe – carsten.tschoepe@charite.de Vice Director of Cardiology Website: www.charite.de
Ludwig-Maximilians-Universität München

Project input will include expertise in diabetic nephropathy and protocols on harvesting kidney samples, plasma and urine. Professor Hans-Joachim Anders – hjanders@med.uni-muenchen.de Head of Nephrology: Inner City Campus Website: www.uni-muenchen.de
Orbsen Therapeutics Limited

Project input will include providing S2-SSC and PA-SSC from murine, rat, rabbit and human marrow together with background data. Website: www.orbsentherapeutics.com Dr. Stephen Elliman Interview Full transcript here.
Owl Biomedical Inc

Project input will include expertise in isolation of S2+,S2-SSCs from bone marrow and development of world’s first cGMP compliant FACS Nanosorter® specifically for S2-SSC isolation. Website: www.owlbiomedical.com Dr. John Foster – john@owlbiomedical.com CEO
Pintail Ltd

Project input will include provision of data management facility to store and share pre-clinical data, day to day project administration and expertise in dissemination and exploitation. Website: http://www.pintail.eu/
Steno Diabetes Center A/S

Project input will include oversight of Phase 1b clinical trial. Website: www.steno.dk Contact: Professor John Nolan – jjnl@steno.dk Diabetologist
Academisch Ziekenhuis Leiden – Leids Universitair Medisch Centrum (LUMC)

Project input will include expertise in all aspects of S2-SSC product life cycle, protocols in tissue acquisition, S2-SSC isolation, expansion, scale up and cryopreservation. Website: www.lumc.nl Contact: Professor Willem Fibbe – w.e.fibbe@lumc.nl Chair of the Department of Immunohematology and Blood Transfusion